Great time at the 2025 SITC annual meeting. Learned a lot this week and got to catch up with colleagues! @osuwexmed.bsky.social @osucccjames.bsky.social @sitcancer.bsky.social

Our work was highlighted by @jguerriero.bsky.social at #SITC25 today, session "Cellular Therapies for Solid Tumors, Cell Therapies beyond CAR T Cells." Check out the pre-print on BioRxiv! @sitcancer.bsky.social @sgholamin.bsky.social @nebanovich.bsky.social

Congratulations to the 2025 Martin "Mac" Cheever Excellence in Clinical Trial Awardees! These brilliant early career investigators are continuing the trail blazed by Dr. Cheever. Please join us in recognizing Oluwadunni Emiloju, MD, Emory University and Lee Hong, PhD, Scripps Health.

Students from the D.C. area connect with local mentors to learn about immunotherapy and the various potential career paths within the field. Special thanks to organizers Drs. Chelsea C. Pinnix, Avery Posey and our Workforce Development Committee. #SITC25 Undergrads in STEM Program.

Dr. Wim Vos CEO #Radiomics_Bio opens session on Imaging, radionics, and integrated biomarkers at #SITC2025 / important topic that holds promise to predict response and accelerate treatment decisions for patients with cancer #Radiomics

Are you using the right tumor micro environment model? Cancer is a disease of aging @sitcancer.bsky.social #SITC25 great session at the annual meeting on the aged immune system and the tumor micro environment moderated by Drs DA and A Weeraratna.

We're here, at Society for Immunotherapy of Cancer (SITC) @sitcancer.bsky.social and ready to empower you to use true #spatialmultiomics to accelerate your immunotherapy research. Join the Advanced Cell Diagnostics and Lunaphore team at booth #603 and discover our extended #spatial portfolio.

Had a great time discussing AI advances in TCR modeling @sitcancer.bsky.social

Grateful to everyone who joined our Hill visits this week advocating for stronger support of biomedical research. Your efforts to champion increased NIH funding help drive discovery and improve lives. #SITContheHill @immunegirl.bsky.social @cgtgaithersburg.bsky.social @doctweettweet.bsky.social 🧪

Excited to present our work at SITC this weekend! Join us on Saturday for Ryma Toumi's poster #796: Engineering T cells to reprogram inhibitory macrophages #SITC2025 #CancerResearch

Great session exploring neuro-immunology in cancer immunotherapy #SITC25. Clearly we have much to learn about this little studied part of tumor biology. U Von Adrian demonstrated how afferent neurons organize and activate MDSCs at the tumor site @sitcancer.bsky.social

Can't wait for The CheckPoints to rock out Saturday night during our 40th Anniversary Party! Bid on original drawings by some of our very own CheckPoints band members! https://givebutter.com/c/40YearsForward/auction

Thanks for everyone who joined the #SITCFunRun and kicked off their day with fresh air and great views! Let's keep the energy going! #SITC25

Thank you for joining us as we took a step back in time and celebrated all we have accomplished in immuno-oncology over the past 40 years! #SITC25 Learn more here: https://www.sitcancer.org/2025/home#SITC25

We had a successful Meet-the-Expert Lunch at #SITC25. Where early career scientists interacted and connected with experts in key areas of immunotherapy!

Deng Pan lab report that an in vivo #CRISPR-Cas9 screen reveals that inactivation of Calreticulin (CALR) potentiates CD8⁺ T cell-mediated anti-tumor immunity and overcomes tumor immune evasion. rupress.org/jem/article/... 📘 In #cancer #immunotherapy collection: rupress.org/jem/collecti... #SITC25

Ferry, Goldrath et al. show that differentiation of tissue-resident memory T cells (TRM) is accompanied by the upregulation of the conventional DC1 (cDC1) chemoattractant, Xcl1. rupress.org/jem/article/... 📘 In #cancer #immunotherapy collection: rupress.org/jem/collecti... #SITC25

Our 2025 Workshop, “Leveraging the Power of Artificial Intelligence to Foster Progress in Immuno-oncology..." educated the IO community to develop new cancer immunotherapies and improve patient care with AI. @jasmineplummer.bsky.social @aruthak.bsky.social @fertiglab.bsky.social @dinler.bsky.social

4 decades of IO – Celebrating 40 years of SITC. In 2024, we published “Challenges and opportunities in cancer immunotherapy: a SITC strategic vision”. We also announced a vision for 100 novel IO agents to be approved by 2034 with IO Drug Development Summit in Boston, MA

The Sparkathon program brought early career investigators to connect with established leaders in cancer immunotherapy at #SITC25! Special thanks to organizers @marcoruella.bsky.social and Jennifer Guerriero, PhD#SITC25

Excited to be attending my first SITC Annual Meeting! On Friday, Brandon Fischer from @nebanovich.bsky.social will present a poster on some of our work on Chlorotoxin CAR T cells. Check it out! #SITC25

Leading experts from the FDA and key stakeholders from industry and biotech discuss pressing topics in IO drug development. Biotech Regulatory Roundtable at #SITC25

Hill Day @sitcancer.bsky.social sharing our support for the NIH and immunotherapy for cancer w Dr Robyn Gartrell and Andrew Donlon from Rep McClain Delaney’s House Office. Thanks also to staffers from Sen Van Hollen and Alsobrooks office for hosting us as well.

4 decades of IO – Celebrating 40 years of SITC. In 2023, our Annual Meeting abstracts set a record with 1,640 submissions. We held our first Spring Scientific in Denver, CO. We also held our first annual business financing event at the New York Stock Exchange (NYSE).

SITC thanks all the volunteers for assisting with today’s hill visits. SITC members held Congressional meetings on a host of important issues affecting cancer immunotherapy research and our next generation of scientists. #SITContheHill

SITC is excited to engage in a full slate of in-person Congressional hill visits this year featuring SITC members advocating for the next generation of scientists and cancer immunotherapy. #SITContheHill

Recent federal actions have posed challenges to the biomedical research landscape so it's essential to unite our community to exchange knowledge. Join a SITC Member-Only Town Hall Webinar, "The State of Play in Immunotherapy Research" on Nov. 10. Register: sitc.execinc.com/edibo/THWS25...

@transgene.bsky.social  & @nec.bio.BV présentent de nouvelles données d’immunologie de la Phase I de TG4050 (VTIN) au @sitcancer.bsky.social 2025. Ces données démontrent le potentiel prometteur de TG4050 à réduire le risque de récidive. 📰 communiqué de presse 👉 https://shorturl.at/MCXxp

Our science at SITC -2 abstracts in the top 150 #Miltenyi #SITC25 #SITC2025 MSLN armored CAR-T (208), PSMA armored CAR-T (228) Spatial proteomics of post Tx sarcoma (243) CD5 CAR-NK (252) BCMA bi-paratopic CAR-T (292) CD276 CAR-T fitness (295) hypoxia expanded NK cells (390) @sitcancer.bsky.social

🚨 irAE aficionados! This Friday! @aspire-cop.bsky.social is at @sitcancer.bsky.social 🥳 ⏱️4-6p 📍Chesapeake Rm 2-3 More details below:

📰 MaaT Pharma To Present Updated Preclinical Data at SITC (@sitcancer.bsky.social) 2025. We’re excited to share promising updated results for MaaT034 showing immune activation and anti-tumor activity in germ-free models. 👉 Full press release: www.maatpharma.com/november-5-2...

Catherine Phelps from @upmc.com representing #SITC Talks on how #exercise can improve outcome - role for #microbial #metabolite #formate on mediating #anticancer #immunity / #WIC2025 #SITC2025

#SITC25 registration is open! Stop to grab your badge and explore our 40-year Timeline Walkthrough honoring the innovators and partners that supported us along the way!

Bernard A. Fox, Michael Geuenich, Catherine Phelps and other international investigators highlight groundbreaking IO advances during the 6th World Immunotherapy Council #SITC25

The first day of #SITC25 is here! We are excited for a week filled with cutting-edge science, interactive programming and networking opportunities.

4 decades of IO – Celebrating 40 years of SITC. In 2022, we had a record-breaking Annual Meeting & Pre-Conference Programs. We launched two new programs: Undergraduates in STEM & the Clinical Immuno-Oncology Network (SCION) program. Learn more: https://www.sitcancer.org/2025/home

SITC 2025, our 40th Anniversary Annual Meeting & Pre-Conference Programs starts tomorrow! Get ahead of all the amazing science and view the accepted Regular & YIA abstracts available at #SITC25. https://ow.ly/yZoL50XmQ9z#SITC25

You can still join SITC 2025 onsite or virtually! Don't miss groundbreaking research driving breakthroughs in cancer immunotherapy. Register now: https://ow.ly/X8Uu50XlXS7 #SITC25

Delighted to be attending #SITC25 @sitcancer.bsky.social! Please let me know if you'd like to chat about your work! 🔬

4 decades of IO – Celebrating 40 years of SITC. In 2021, the Academy of Immuno-Oncology inducted the first class of Fellows. SITC launched the CPG mobile app and two new webinar series - Targets for Cancer Immunotherapy: A Deep Dive and SITC-NCI Computational Immuno-oncology Webinars.

We’re gearing up for #SITC2025! We will share the latest research on our lead investigative cell therapy intended for mCRPC, CAR T cell therapy design, and our foundation model predicting targets for overcoming T cell exhaustion. Join us Nov 7–9: bit.ly/3JHY0wb @sitcancer.bsky.social #CellTherapy

Recent federal actions have posed challenges to the biomedical research landscape so it's essential to unite our community to exchange knowledge. Join a SITC Member-Only Town Hall Webinar, "The State of Play in Immunotherapy Research" on Nov. 10. Register: sitc.execinc.com/edibo/THWS25...

4 decades of IO – Celebrating 40 years of SITC. In 2020, our membership surpassed 4,000 members as we launched two programs: the Certificate in Cancer Immunotherapy and Global Access to Immunotherapy. Our Annual Meeting was held fully virtual due to the COVID-19 pandemic.

4 decades of IO – Celebrating 40 years of SITC. In 2019, SITC held two new programs: the Cancer Immunotherapy Winter School, and the Women in Cancer Immunotherapy Network (WIN) Leadership Institute. Visit our website and learn more about these programs: https://www.sitcancer.org

Join us for a night of MAD SCIENCE at the 40th Anniversary Party featuring The CheckPoints! Bidding is now open for the Silent Auction. Make sure you don’t miss this opportunity to own a piece of IO history! Preview the auction items and learn more: https://givebutter.com/c/40YearsForward/auction

4 decades of IO – Celebrating 40 years of SITC. In 2018, the strategic retreat identified global access and impact as the scientific priority for SITC for the next three years. Learn more and attend #SITC25 https://www.sitcancer.org/2025/home#SITC25

Stay in the know with #SITC! Explore our upcoming events, webinars, and important dates by looking at our calendar. Learn More: https://sitcancer.org/get-involved/events/calendar#SITC#Immunotherapy

4 decades of IO – Celebrating 40 years of SITC. In 2017, Lisa H. Butterfield, PhD became the first female president of SITC. We also held the first Sparkathon program, and published the first edition of the Cancer Immunotherapy Principles and Practice textbook!

Our 2025 ACI series concluded with sessions at ACR Convergence (Oct. 23) and APSHO's JADPRO (Oct. 27). Thank you everyone who made this series a roaring success! Missed a program? Access enduring materials: https://www.sitcancer.org/edu/aci Jeffrey Sparks MD MMSc, Elad Sharon, MD, MPH

4 decades of IO – Celebrating 40 years of SITC. In 2016, SITC held over 20 separate educational programs in conjunction with other like-minded organizations. SITC also held the Value Summit at the Annual Meeting. Attend this years meeting #SITC25 https://www.sitcancer.org/2025/home